康希诺：利用搭建的mRNA技术平台在治疗领域持续探索更多适应症

Core Viewpoint - The company, CanSino, is focusing on its core business while exploring additional indications in the treatment field using its mRNA technology platform, with updates to be provided upon significant progress [1]. Group 1 - CanSino is committed to enhancing its main business operations [1]. - The company is leveraging its mRNA technology platform for further exploration in treatment indications [1]. - CanSino will announce any significant advancements in its research and development efforts in a timely manner [1].